Recombinant human papillomavirus nonavalent vaccine in the prevention of cancers caused by human papillomavirus

Clicks: 261
ID: 5792
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Star

Ranked #1,117 of 1,693 articles by views in Infection and drug resistance

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 1,693 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Recombinant human papillomavirus nonavalent vaccine in the prevention of cancers caused by human papillomavirus
Reference Key
zheng2019recombinantinfection Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Zheng Quan Toh;Jennie Kosasih;Fiona M Russell;Suzanne M Garland;Edward K Mulholland;Paul V Licciardi and
Journal Infection and drug resistance
Year 2019
DOI
10.2147/IDR.S178381
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.